Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: A French nationwide cohort study

• Egile Nagusiak: Agathe Turpin (Egilea), Laura Semenzato (Egilea), Stéphane Le Vu (Egilea), Marie-Joëlle Jabagi (Egilea), Kim Bouillon (Egilea), Jérôme Drouin (Egilea), Marion Bertrand (Egilea), Lukshe Kanagaratnam (Egilea), Alain Weill (Egilea), Rosemary Dray-Spira (Egilea), Mahmoud Zureik (Egilea), Jérémie Botton (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2024-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: In spite of major effectiveness, a residual risk after COVID-19 primary vaccination was identified, in particular, for vulnerable individuals of advanced age or with comorbidities. Less is known about the Omicron period in people protected by a booster dose. We aimed to identify the char...